Form D Explorer
Galaxy Diagnostics, Inc. · CIK 1462444

Report a data issueCitable research briefCompare issuerPrivate research collection

Galaxy Diagnostics, Inc.

CIK 1462444 · Corporation · Inc. NORTH CAROLINA · Durham, North Carolina · Biotechnology
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
Apr 22, 2025
through Jun 3, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 22, 2025 · DJun 3, 2026 · DLater minus earlier
Reported offering amount$11,177,342$5,699,460$-5,477,882
Reported amount sold$4,141,184$3,019,645$-1,121,539
Reported investor count—45—
Reported minimum investment$0$0$0

Earlier SEC source: 0001462444-25-000002 · Later SEC source: 0001462444-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Jun 3, 2026

Reported offering amount
$5,699,460
Reported exemptions
Rule 506(b)
Reported amount sold
$3,019,645

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)